提升腫瘤科護理師執行標靶藥物引發皮膚反應之衛教正確執行率

Increasing the Accuracy of Oncology Nurses' Patient Education on Skin Reactions to Targeted Therapies

10.6880/TJON.201903/SP_19.13

林怡君(Yi-Chun Lin)；龔昱如(Yu-Ju kung)；宋瑞蘭(Jui-Lan Sung)；康琇菱(Hsiu-Ling Kamg)；呂佩珍(Pei-Chien Lu)；謝佩琪(Pei-Chi Hsieh)

腫瘤科護理師 ； 標靶藥物 ； 皮膚照護 ； oncology nurse ； target drug ； skin care

腫瘤護理雜誌

19卷增訂刊（2019 / 03 / 01）

151 - 167

繁體中文

提升腫瘤科護理師執行標靶藥物引發皮膚反應衛教正確執行率，有助病患治療期間獲得完善照護。臨床上標靶藥物治療病患常因手足皮膚反應反覆入院，護理師無法提供預防照護，故引發動機。觀察護理師衛教正確執行率46.43%，導因為缺乏標靶藥物皮膚副作用認知、皮膚照護相關輔助工具、皮膚反應評估工具及衛教手冊，無專科訓練及一致性管理流程，故設定提升標靶藥物引發皮膚反應之衛教正確執行率達95%為目的。改善措施：製作使用標靶藥物管理流程、六步驟皮膚照護包、皮膚反應評估工具、皮膚照護衛教手冊及QR code結合照護資訊。執行後照護認知正確率由73%提升為96.33%，衛教正確執行率由46.43%提升到96.43%，已達目的，顯示多元化措施確實可提升護理品質，提供相關護理指導之參考。

Clinically, patients treated with targeted therapies sometimes must repeatedly seek hospital treatment because of skin reactions on their hands and feet. However, nurses generally provide no preventive care for these reactions. The accuracy of oncology nurses' patient care education on skin reactions to targeted therapies can be improved to facilitate the care for oncology patients. Oncology nurses' patient care education of skin reactions was determined to be only 46.43% accurate because the nurses had inadequate knowledge about the skin-related side effects of targeted therapies and lacked proper skincare instruments, skin reaction assessment tools, patient education materials on skincare, specialised training, and a consistent management procedure for targeted therapy administration. This study aimed to increase the accuracy of oncology nurses' patient care education of skin reactions to targeted therapies to 95%. To achieve this goal, a management procedure for targeted therapy administration, a six-step skincare kit, an assessment tool for skin reactions to targeted therapies, patient education materials about skincare, and a QR code (that directs patients to skincare information) were developed. Consequently, the accuracy rate of nursing cognitive assessment increased from 73% to 96.33%, the nurses' accuracy of patient care education about skin reactions to targeted therapies increased from 46.43% to 96.43%. Such an improvement can contribute towards the quality of nursing care provided to patients receiving targeted therapies.

1. Burke, M. B.,Ciccolini, K.,Mekas, M.,Burke, S.(2018).Dermatologic reactions to targeted therapy: a focus on epidermal growth factor receptor inhibitors and nursing care.Nurs Clin North Am,52(1),83-113.
2. Cubero, D. G.,Zugaib Abdalla, B. M,Schoueri, J.,Lopes, F. L,Turke, K. C.,Guzman, J.,Fabra, D. G.(2018).Cutaneous side effects of molec-ularly targeted therapies for the treatment of solid tumors.Drugs in Context,7,1-11.
3. Fingeret, M. C.,Yuan, Y.,Urbauer, D.,Weston, J.,Nipomnick, S.,Weber, R.(2011).The nature and extent of body image concerns among sur-gically treated patients with head and neck can-cer.Psycho-Oncology,21(8),836-844.
4. Grande, R.,Narducci, F.,Bianchetti, S.,Mansueto, G.,Gemma, D.,Sperduti, I.,Gamucci, T.(2013).Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. a phase II study.Supportive Care in Cancer,21(6),1691-1695.
5. Lacouture, M. E.,Anadkat, M. J.,Bensadoun, R. J.,Bryce, J.,Chan, A.,Epstein, J. B.,Murphy, B. A.(2011).Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-as-sociated dermatologic toxicities.Supportive Care in Cancer,19(8),1079-1095.
6. Melosky, B.(2012).Supportive care treatments for toxicities of anti-EGFR and other target-ed agents.Current Oncology,19(1 Suppl.),S59-S63.
7. Rosell, R.,Carcereny, E.,Gervais, R.,Vergnene-gre, A.,Massuti, B.,Felip, E.,Paz-Ares, L.(2012).Erlotinib versus standard chemo-therapy as first-line treatment for European patients with advanced EGFR mutation-pos-itive non-smallcell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial.The Lancet Oncology,13(3),239-246.
8. 美國國家癌症研究院（2009）．第四版毒性評估標準．2015年7月1日取自http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
9. 張黎露, L. L.,劉滄梧, T. W.,鄧新棠, S. T.,邱昌芳, C. F.,姜紹青, S. C.,張美娟, M. C.,張文, C. W.(2015)。台灣跨專業共識之化學治療安全作業指引—第一版與第二版修訂對照表。腫瘤護理雜誌，15，109-110。
10. 陳美雪, M. H.,林淑媛, S. Y.(2012)。光碟教學對改善長照機構護理人員在導尿管相關泌尿道感染知識之成效。護理暨健康照護研究，8(1)，61-69。
11. 衛生福利部（2015）．103年死因統計．2015年10月21日取自http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=5488